CP21R7 |
A potent and selective inhibitor of GSK3β; used as an activator of st… |
1 mg |
20573-1 |
More Info
|
CP21R7 |
A potent and selective inhibitor of GSK3β; used as an activator of st… |
10 mg |
20573-10 |
More Info
|
CP21R7 |
A potent and selective inhibitor of GSK3β; used as an activator of st… |
25 mg |
20573-25 |
More Info
|
CP21R7 |
A potent and selective inhibitor of GSK3β; used as an activator of st… |
5 mg |
20573-5 |
More Info
|
CPS2 |
A PROTAC that drives Cdk2 degradation; selectively degrades Cdk2 (IC50 = 2… |
1 mg |
40457-1 |
More Info
|
CPS2 |
A PROTAC that drives Cdk2 degradation; selectively degrades Cdk2 (IC50 = 2… |
10 mg |
40457-10 |
More Info
|
CPS2 |
A PROTAC that drives Cdk2 degradation; selectively degrades Cdk2 (IC50 = 2… |
5 mg |
40457-5 |
More Info
|
CPSI-1306 |
A MIF inhibitor; decreases skin thickness and MPO activity and induces ker… |
10 mg |
29905-10 |
More Info
|
CPSI-1306 |
A MIF inhibitor; decreases skin thickness and MPO activity and induces ker… |
25 mg |
29905-25 |
More Info
|
CPSI-1306 |
A MIF inhibitor; decreases skin thickness and MPO activity and induces ker… |
5 mg |
29905-5 |
More Info
|
CPSI-1306 |
A MIF inhibitor; decreases skin thickness and MPO activity and induces ker… |
50 mg |
29905-50 |
More Info
|
8-CPT-Cyclic AMP (sodium salt) |
A lipophilic activator of PKA and PKG (Ka = 0.05 and 0.11 µM, respec… |
10 mg |
12011-10 |
More Info
|
8-CPT-Cyclic AMP (sodium salt) |
A lipophilic activator of PKA and PKG (Ka = 0.05 and 0.11 µM, respec… |
25 mg |
12011-25 |
More Info
|
8-CPT-Cyclic AMP (sodium salt) |
A lipophilic activator of PKA and PKG (Ka = 0.05 and 0.11 µM, respec… |
50 mg |
12011-50 |
More Info
|
CPTH6 (hydrobromide) |
A thiazole derivative that inhibits the lysine acetyltransferase activity… |
1 mg |
19828-1 |
More Info
|
CPTH6 (hydrobromide) |
A thiazole derivative that inhibits the lysine acetyltransferase activity… |
10 mg |
19828-10 |
More Info
|
CPTH6 (hydrobromide) |
A thiazole derivative that inhibits the lysine acetyltransferase activity… |
5 mg |
19828-5 |
More Info
|
CPTH2 (hydrochloride) |
Specifically inhibits Gcn5-dependent acetylation of histone H3K14 at a con… |
10 mg |
12086-10 |
More Info
|
CPTH2 (hydrochloride) |
Specifically inhibits Gcn5-dependent acetylation of histone H3K14 at a con… |
5 mg |
12086-5 |
More Info
|
CPYPP |
An inhibitor of DOCK2 (IC50 = 22.8 µM for its GEF activity), DOCK5,… |
10 mg |
17386-10 |
More Info
|
CPYPP |
An inhibitor of DOCK2 (IC50 = 22.8 µM for its GEF activity), DOCK5,… |
25 mg |
17386-25 |
More Info
|
CPYPP |
An inhibitor of DOCK2 (IC50 = 22.8 µM for its GEF activity), DOCK5,… |
5 mg |
17386-5 |
More Info
|
CPYPP |
An inhibitor of DOCK2 (IC50 = 22.8 µM for its GEF activity), DOCK5,… |
50 mg |
17386-50 |
More Info
|
[3,2-c]Pyrazole-5α-androstan-17β-ol |
An anabolic androgenic steroid that is closely related to stanozolol |
1 mg |
17943-1 |
More Info
|
[3,2-c]Pyrazole-5α-androstan-17β-ol |
An anabolic androgenic steroid that is closely related to stanozolol |
10 mg |
17943-10 |
More Info
|
[3,2-c]Pyrazole-5α-androstan-17β-ol |
An anabolic androgenic steroid that is closely related to stanozolol |
25 mg |
17943-25 |
More Info
|
[3,2-c]Pyrazole-5α-androstan-17β-ol |
An anabolic androgenic steroid that is closely related to stanozolol |
5 mg |
17943-5 |
More Info
|
[3,2-c]Pyrazole-androst-4-en-17β-ol |
A steroidal heterocyclic compound that is classified as a controlled subst… |
1 mg |
17930-1 |
More Info
|
[3,2-c]Pyrazole-androst-4-en-17β-ol |
A steroidal heterocyclic compound that is classified as a controlled subst… |
10 mg |
17930-10 |
More Info
|
[3,2-c]Pyrazole-androst-4-en-17β-ol |
A steroidal heterocyclic compound that is classified as a controlled subst… |
25 mg |
17930-25 |
More Info
|
[3,2-c]Pyrazole-androst-4-en-17β-ol |
A steroidal heterocyclic compound that is classified as a controlled subst… |
5 mg |
17930-5 |
More Info
|
CRAMP (140-173) (mouse) (trifluoroacetate salt) |
An antimicrobial peptide; active against K. pneumoniae in vitro at 1 &micr… |
1 mg |
37502-1 |
More Info
|
CRAMP (140-173) (mouse) (trifluoroacetate salt) |
An antimicrobial peptide; active against K. pneumoniae in vitro at 1 &micr… |
10 mg |
37502-10 |
More Info
|
CRAMP (140-173) (mouse) (trifluoroacetate salt) |
An antimicrobial peptide; active against K. pneumoniae in vitro at 1 &micr… |
5 mg |
37502-5 |
More Info
|
CRANAD 2 |
An affinity probe for Aβ; has high affinity for Aβ (Kd = 38 nM);… |
1 mg |
19814-1 |
More Info
|
CRANAD 2 |
An affinity probe for Aβ; has high affinity for Aβ (Kd = 38 nM);… |
10 mg |
19814-10 |
More Info
|
CRANAD 2 |
An affinity probe for Aβ; has high affinity for Aβ (Kd = 38 nM);… |
25 mg |
19814-25 |
More Info
|
CRANAD 2 |
An affinity probe for Aβ; has high affinity for Aβ (Kd = 38 nM);… |
5 mg |
19814-5 |
More Info
|
CRANAD 28 |
A fluorescent affinity probe for amyloid-β with ex./em. spectra of 49… |
1 mg |
19816-1 |
More Info
|
CRANAD 28 |
A fluorescent affinity probe for amyloid-β with ex./em. spectra of 49… |
10 mg |
19816-10 |
More Info
|
CRANAD 28 |
A fluorescent affinity probe for amyloid-β with ex./em. spectra of 49… |
5 mg |
19816-5 |
More Info
|
CRANAD 28 |
A fluorescent affinity probe for amyloid-β with ex./em. spectra of 49… |
500 µg |
19816-500 |
More Info
|
Crassicauline A |
A diterpene alkaloid with analgesic activity; inhibits acetic acid-induced… |
10 mg |
34674-10 |
More Info
|
Crassicauline A |
A diterpene alkaloid with analgesic activity; inhibits acetic acid-induced… |
100 mg |
34674-100 |
More Info
|
Crassicauline A |
A diterpene alkaloid with analgesic activity; inhibits acetic acid-induced… |
5 mg |
34674-5 |
More Info
|
Crassicauline A |
A diterpene alkaloid with analgesic activity; inhibits acetic acid-induced… |
50 mg |
34674-50 |
More Info
|
CrAssPhage qPCR Assay |
A mix of primers and probe targeting CrAssphage genomic DNA (the gene of a… |
1 each |
40680-10020 |
More Info
|
C-Reactive Protein (human, recombinant) |
Source: Recombinant human C-reactive protein expressed in HEK293 cells &bu… |
200 µg |
37018-200 |
More Info
|
Creatine (hydrate) |
A derivative of glycine; phosphorylated to creatine phosphate, which is us… |
100 g |
36940-100 |
More Info
|
Creatine (hydrate) |
A derivative of glycine; phosphorylated to creatine phosphate, which is us… |
250 g |
36940-250 |
More Info
|
Creatine (hydrate) |
A derivative of glycine; phosphorylated to creatine phosphate, which is us… |
50 g |
36940-50 |
More Info
|
Creatine (hydrate) |
A derivative of glycine; phosphorylated to creatine phosphate, which is us… |
500 g |
36940-500 |
More Info
|
Creatine Phosphate |
A phosphorylated form of creatine; reduces hydrogen peroxide- and ferrous… |
1 g |
35598-1 |
More Info
|
Creatine Phosphate |
A phosphorylated form of creatine; reduces hydrogen peroxide- and ferrous… |
10 g |
35598-10 |
More Info
|
Creatine Phosphate |
A phosphorylated form of creatine; reduces hydrogen peroxide- and ferrous… |
5 g |
35598-5 |
More Info
|
Creatine Phosphate (sodium salt hydrate) |
A phosphorylated form of creatine; reduces hydrogen peroxide- and ferrous… |
1 g |
37803-1 |
More Info
|
Creatine Phosphate (sodium salt hydrate) |
A phosphorylated form of creatine; reduces hydrogen peroxide- and ferrous… |
10 g |
37803-10 |
More Info
|
Creatine Phosphate (sodium salt hydrate) |
A phosphorylated form of creatine; reduces hydrogen peroxide- and ferrous… |
5 g |
37803-5 |
More Info
|
Creatinine |
The end product of the creatine-creatine phosphate energy shuttle; formed… |
100 g |
31164-100 |
More Info
|
Creatinine |
The end product of the creatine-creatine phosphate energy shuttle; formed… |
250 g |
31164-250 |
More Info
|
Creatinine |
The end product of the creatine-creatine phosphate energy shuttle; formed… |
50 g |
31164-50 |
More Info
|
Creatinine |
The end product of the creatine-creatine phosphate energy shuttle; formed… |
500 g |
31164-500 |
More Info
|
Creatinine-d3 |
An internal standard for the quantification of creatinine by GC- or LC-MS |
1 mg |
16763-1 |
More Info
|
Creatinine-d3 |
An internal standard for the quantification of creatinine by GC- or LC-MS |
10 mg |
16763-10 |
More Info
|
Creatinine-d3 |
An internal standard for the quantification of creatinine by GC- or LC-MS |
5 mg |
16763-5 |
More Info
|
Creatinine-d3 |
An internal standard for the quantification of creatinine by GC- or LC-MS |
500 µg |
16763-500 |
More Info
|
Creatinine ELISA Kit |
Cayman's Creatinine ELISA Kit is a competitive assay that can be used for… |
96 Solid |
502330-96SOLIDWELLS |
More Info
|
Creatinine ELISA Kit |
Cayman's Creatinine ELISA Kit is a competitive assay that can be used for… |
96 Well |
502330-96STRIPWELLS |
More Info
|
Creatinine (serum) Colorimetric Assay Kit |
Cayman's Creatinine (serum) Colorimetric Assay can be used to measure crea… |
192 Well |
700460-2X96WELLS |
More Info
|
Creatinine (urinary) Colorimetric Assay Kit |
Cayman's Creatinine (urinary) Colorimetric Assay Kit can be used to measur… |
480 Well |
500701-480WELLS |
More Info
|
Creatinine (urinary) Colorimetric Assay Kit |
Cayman's Creatinine (urinary) Colorimetric Assay Kit can be used to measur… |
96 Well |
500701-96WELLS |
More Info
|
Crebanine |
An aporphine alkaloid; an antagonist of α7 nAChRs (IC50 = 19.1 &micr… |
1 mg |
36176-1 |
More Info
|
Crebanine |
An aporphine alkaloid; an antagonist of α7 nAChRs (IC50 = 19.1 &micr… |
10 mg |
36176-10 |
More Info
|
Crebanine |
An aporphine alkaloid; an antagonist of α7 nAChRs (IC50 = 19.1 &micr… |
5 mg |
36176-5 |
More Info
|
Crebanine |
An aporphine alkaloid; an antagonist of α7 nAChRs (IC50 = 19.1 &micr… |
500 µg |
36176-500 |
More Info
|